AVACTA GROUP PLC
Developing targeted cancer therapies with a platform that delivers drugs directly to tumors.
AVCT | IL
Overview
Corporate Details
- ISIN(s):
- GB00BYYW9G87
- LEI:
- 2138009U3EG31OPMGH36
- Country:
- United Kingdom
- Address:
- UNIT 20 ASH WAY, THORP ARCH ESTATE, LS23 7FA WETHERBY
- Website:
- https://avacta.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Avacta Group PLC is a clinical-stage life sciences company focused on developing innovative cancer therapies through its proprietary pre|CISION® platform. This peptide drug conjugate (PDC) technology is designed to deliver anti-tumor payloads directly to the tumor, aiming to improve the safety and efficacy of potent cancer drugs and expand their therapeutic use. The company's pipeline includes targeted oncology drugs, with a key focus on advancing its assets through clinical trials and strategic partnerships. While historically involved in diagnostics, Avacta is increasingly concentrating its resources on its core therapeutics division.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for AVACTA GROUP PLC and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-15 08:00 |
Report Publication Announcement
Notice of Interim Results
|
English | 17.8 KB | |
| 2025-09-09 08:00 |
Regulatory News Service
Shortlisted for AIM Awards Technology of the Year
|
English | 15.2 KB | |
| 2025-07-30 08:00 |
Earnings Release
Avacta to Present at ESMO Congress
|
English | 17.3 KB | |
| 2025-07-28 08:48 |
M&A Activity
Agreement to Sell Coris Bioconcept SRL
|
English | 17.8 KB | |
| 2025-07-21 08:00 |
Capital/Financing Update
Payment of Convertible Bond Installment
|
English | 16.0 KB | |
| 2025-07-17 08:00 |
Share Issue/Capital Change
Equity fundraise of £3.25 million
|
English | 42.4 KB | |
| 2025-07-02 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
|
English | 29.4 KB | |
| 2025-07-02 08:00 |
Regulatory News Service
Q2 2025 Business Update
|
English | 25.6 KB | |
| 2025-06-06 08:00 |
Earnings Release
Preliminary Full Year 2024 Results
|
English | 512.2 KB | |
| 2025-05-28 08:00 |
Board/Management Information
Board appointments
|
English | 30.9 KB | |
| 2025-05-27 08:00 |
Report Publication Announcement
Update on timing of preliminary results
|
English | 16.4 KB | |
| 2025-05-15 08:00 |
Report Publication Announcement
Notice of Results
|
English | 15.4 KB | |
| 2025-05-08 08:30 |
Share Issue/Capital Change
Block Listing Application to AIM
|
English | 13.2 KB | |
| 2025-04-28 18:52 |
Share Issue/Capital Change
Block Listing Six Monthly Return
|
English | 25.8 KB | |
| 2025-03-31 08:00 |
Business and Financial Review
Avacta Quarterly Update
|
English | 24.0 KB |
Automate Your Workflow. Get a real-time feed of all AVACTA GROUP PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for AVACTA GROUP PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
